Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.

Miguel de MulderDevi SenGuptaSteven G DeeksJeffrey N MartinChristopher D PilcherFrederick M HechtJonah B SachaDouglas F NixonHenri-Alexandre Michaud

Published in: Retrovirology (2017)

HIV elite controllers had a strong cellular and antibody response against HERV-K (HML-2) Gag directed mainly against the Capsid region. Collectively, these data suggest that anti-HERV-K (HML-2) antibodies targeting capsid could have an immunoprotective effect in HIV infection.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv testing
hiv aids
hepatitis c virus
men who have sex with men
body composition
electronic health record
south africa
cancer therapy
big data
drug delivery